NCT05320094View on ClinicalTrials.gov

A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

September 11, 2022

Study Completion Date

September 11, 2022

Conditions
Healthy Participants
Interventions
DRUG

Mavacamten

Specified dose on specified days

DRUG

Activated Charcoal with Sorbitol

Specified dose on specified days

Trial Locations (1)

75247-4989

Local Institution - 0001, Dallas

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05320094 - A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants | Biotech Hunter | Biotech Hunter